Evidence map›Paper›PMID 36968612›Full record

ArticleFrontiers in genetics2023

Correction of

Zhiqing Hu, Yong Wu, Rou Xiao, Junya Zhao, Yan Chen, Lingqian Wu, Miaojin Zhou, Desheng Liang

Open access · goldFull text read
In one paragraph

Article in Frontiers in genetics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Advancements in CRISPR-basedFrontiers in genome editing · 2026
    Review
  3. Exploring gene editing as a potential therapeutic strategy for hemophilia.Frontiers in bioengineering and biotechnology · 2026
    Review
  4. Article
  5. Review
  6. CRISPR-based editing strategies to rectifyMolecular therapy. Nucleic acids · 2024
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Zhiqing HuCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha, China.
Yong WuShenzhen Baoan Women's and Children's Hospital, Jinan University, Shenzhen, China.
Rou XiaoCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha, China.
Junya ZhaoCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha, China.
Yan ChenCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha, China.
Lingqian WuCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha, China.
Miaojin ZhouCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha, China.
Desheng LiangCenter for Medical Genetics, School of Life Sciences, Central South University, Changsha, China.
Central South University · CNJinan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

F8 intron 1 inversionhemophilia Ahepatocyte-like cellshomology-mediated end joiningin situ gene addition

Identifiers

PMID36968612
PMCPMC10033665
OpenAlexW4323666014

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read35
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.